Home > Annual Financials > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS Financial Statement Analysis
[BOM: 540788]

The Revenues of ASPIRA PATHLAB & DIAGNOSTICS have increased by 66.60% YoY .
The Earnings Per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS has increased by Positive YoY.
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Annual Financial Results
[BOM: 540788]

ConsolidatedMar2025
Mar2024
Operating Income ₹22 Cr₹13 Cr
Expenses ₹18 Cr₹14 Cr
Operating Profit (Excl OI) ₹3.53 Cr₹-1.19 Cr
Other Income ₹0.39 Cr₹0.42 Cr
Interest ₹0.35 Cr₹0.37 Cr
Depreciation ₹1.49 Cr₹1.54 Cr
Profit Before Tax ₹2.02 Cr₹-2.67 Cr
Profit After Tax ₹2.02 Cr₹-2.67 Cr
Consolidated Net Profit ₹2.02 Cr₹-2.67 Cr
Earnings Per Share (Rs)₹1.97₹-2.60
PAT Margin (%)9.19-20.24
ROE(%)18.13-26.34
ROCE(%)19.27-20.54
Total Debt/Equity(x)0.100.11

Key Financials

Market Cap : ₹ 135.2 Cr
Revenue (TTM) : ₹ 22.6 Cr
Net Profit(TTM) : ₹ 2.6 Cr
EPS (TTM) : ₹ 2.5
P/E (TTM) : 52.8

Industry Peers & Returns1W1M1Y
ASPIRA PATHLAB & DIAGNOSTICS 1% 37.6% 122.7%
APOLLO HOSPITALS ENTERPRISE -8.7% -7.4% 6.7%
MAX HEALTHCARE INSTITUTE -6.8% -6.2% -18.4%
FORTIS HEALTHCARE -5.9% -13.7% -18.6%
ASTER DM HEALTHCARE -6.7% -6.5% 8.6%
NARAYANA HRUDAYALAYA -6.4% -10.1% 4.2%
GLOBAL HEALTH -9.2% -6.8% 2.7%
KRISHNA INSTITUTE OF MEDICAL SCIENCES -5.8% -3.2% 2.2%
DR LAL PATHLABS 2.8% 5.4% 22%


ASPIRA PATHLAB & DIAGNOSTICS Revenues
[BOM: 540788]

Y-o-Y

66.60 %

5 Yr CAGR

66.60 %

Years Revenues % Change
Mar2025 ₹22 Cr
66.60
Mar2024 ₹13 Cr -


ASPIRA PATHLAB & DIAGNOSTICS Operating Profit
[BOM: 540788]

Y-o-Y

Positive

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2025 ₹3.53 Cr
Positive
Mar2024 ₹-1.19 Cr -

Operating Margins
Y-o-Y

Positive

5 Yr CAGR

Positive

Years Operating Margin% % Change
Mar2025 16.02%
Positive
Mar2024 -8.99% -

ASPIRA PATHLAB & DIAGNOSTICS Profit After Tax
[BOM: 540788]

Y-o-Y

Positive

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2025 ₹2.02 Cr
Positive
Mar2024 ₹-2.67 Cr -

PAT Margins
Y-o-Y

Positive

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2025 9.19 %
Positive
Mar2024 -20.24 % -

ASPIRA PATHLAB & DIAGNOSTICS Earnings Per Share (EPS)
[BOM: 540788]

Y-o-Y

Positive

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹1.97
Positive
Mar2024 ₹-2.60 -

ASPIRA PATHLAB & DIAGNOSTICS Return on Capital Employed (ROCE)
[BOM: 540788]

Y-o-Y

Positive

5 Yr CAGR

Positive

Years ROCE % Change
Mar2025 19.27%
Positive
Mar2024 -20.54% -

ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex

Current Share Price : ₹131.3
Current MarketCap: ₹ 135.2 Cr
Updated EOD on :Oct 01,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS

1%

37.6%

122.7%

SENSEX

-2.3%

-6.6%

-12%

ASPIRA PATHLAB & DIAGNOSTICS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ASPIRA PATHLAB & DIAGNOSTICS Financials


How the annual revenues of ASPIRA PATHLAB & DIAGNOSTICS have changed ?

The Revenues of ASPIRA PATHLAB & DIAGNOSTICS have increased by 66.60% YoY .

How the Earnings per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS have changed?

The Earnings Per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS has increased by Positive YoY .